A Global Perspective on Emerging BTK Inhibitor Therapy Data for CLL and MCL in 2022

2022 ASCO Annual Meeting, June 3-7, 2022, in Chicago, Illinois, USA; EHA 2022 Congress, June 9-12, 2022, in Vienna, Austria; 2022 Pan Pacific Lymphoma Conference, July 18-22, 2022, in Koloa, Hawaii, USA; ESMO 2022 Annual Congress, September 9-13, 2022, in Paris, France; 2022 SOHO Annual Meeting, September 28 - October 1, 2022, in Houston, Texas, USA
Download this living slideset featuring new data from conference presentations on the use of BTK inhibitors to treat CLL and MCL. This slideset will be updated throughout 2022 and include key findings from the ASCO, EHA, Pan Pacific, ESMO, and SOHO annual meetings, so check back often.

person default
Othman Al-Sawaf, MD
Lydia Scarfò, MD
Julie M. Vose, MD, MBA
Format: Microsoft PowerPoint (.ppt)
File Size: 1.31 MB
Released: July 29, 2022

Acknowledgements

Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Lilly

Related Content

Commentary on the evolving therapeutic landscape in peripheral T-cell lymphomas with a focus on EZH1/2 inhibition, from Clinical Care Options (CCO)

Steven M. Horwitz, MD
Program Director
Pamela B. Allen, MD Pierluigi Porcu, MD
Released: August 8, 2022

Video featuring Jesús Berdeja, MD, and Sagar Lonial, MD, discussing the latest evidence on approved and investigational CAR T-cell therapies for multiple myeloma, from Clinical Care Options (CCO)

Jesús G. Berdeja, MD Sagar Lonial, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 5, 2022 Expired: August 4, 2023

Expert webcast recording of live webinar on selecting therapy and managing toxicities for indolent B-cell lymphomas, from Clinical Care Options (CCO)

Elizabeth Brém, MD
Program Director
Christopher R. Flowers, MD, MS
Program Director
person default Pallawi Torka, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: August 3, 2022 Expired: August 2, 2023

Pharmacists review the latest findings in the treatment of relapsed/refractory multiple myeloma and provide clinical insights based on their personal experiences, from Clinical Care Options (CCO).

Rebecca Gonzalez, PharmD, BCOP Donald C. Moore, PharmD, BCPS, BCOP, DPLA Released: July 29, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings